1.
Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-cell recovery. Radiol Oncol. 2026;60(1):76-85. Accessed September 21, 2026. https://radioloncol.com/index.php/ro/article/view/4845